BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 29667615)

  • 1. Vitamin D in prostate cancer.
    Trump DL; Aragon-Ching JB
    Asian J Androl; 2018; 20(3):244-252. PubMed ID: 29667615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of nuclear receptor ligands with the Vitamin D signaling pathway in prostate cancer.
    Peehl DM; Feldman D
    J Steroid Biochem Mol Biol; 2004 Nov; 92(4):307-15. PubMed ID: 15663994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D and prostate cancer.
    Konety BR; Getzenberg RH
    Urol Clin North Am; 2002 Feb; 29(1):95-106, ix. PubMed ID: 12109360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D in Prostate Cancer.
    Ahn J; Park S; Zuniga B; Bera A; Song CS; Chatterjee B
    Vitam Horm; 2016; 100():321-55. PubMed ID: 26827958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D and prostate cancer prevention and treatment.
    Chen TC; Holick MF
    Trends Endocrinol Metab; 2003 Nov; 14(9):423-30. PubMed ID: 14580762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathways mediating the growth-inhibitory actions of vitamin D in prostate cancer.
    Peehl DM; Krishnan AV; Feldman D
    J Nutr; 2003 Jul; 133(7 Suppl):2461S-2469S. PubMed ID: 12840225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D and prostate cancer: biologic interactions and clinical potentials.
    Miller GJ
    Cancer Metastasis Rev; 1998-1999; 17(4):353-60. PubMed ID: 10453279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale for combination ketoconazole/ vitamin D treatment of prostate cancer.
    Peehl DM; Seto E; Feldman D
    Urology; 2001 Aug; 58(2 Suppl 1):123-6. PubMed ID: 11502466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D and vitamin D analogs as cancer chemopreventive agents.
    Guyton KZ; Kensler TW; Posner GH
    Nutr Rev; 2003 Jul; 61(7):227-38. PubMed ID: 12918875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discordant Health Implications and Molecular Mechanisms of Vitamin D in Clinical and Preclinical Studies of Prostate Cancer: A Critical Appraisal of the Literature Data.
    Fendler A; Stephan C; Ralla B; Jung K
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer.
    Li H; Stampfer MJ; Hollis JB; Mucci LA; Gaziano JM; Hunter D; Giovannucci EL; Ma J
    PLoS Med; 2007 Mar; 4(3):e103. PubMed ID: 17388667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D and pancreatic cancer.
    Barreto SG; Neale RE
    Cancer Lett; 2015 Nov; 368(1):1-6. PubMed ID: 26276715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D receptor: a potential target for intervention.
    Johnson CS; Hershberger PA; Bernardi RJ; Mcguire TF; Trump DL
    Urology; 2002 Sep; 60(3 Suppl 1):123-30; discussion 130-1. PubMed ID: 12231068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcitriol in the treatment of prostate cancer.
    Beer TM; Myrthue A
    Anticancer Res; 2006; 26(4A):2647-51. PubMed ID: 16886675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D in the prevention and treatment of prostate cancer.
    Konety BR; Johnson CS; Trump DL; Getzenberg RH
    Semin Urol Oncol; 1999 May; 17(2):77-84. PubMed ID: 10332920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of vitamin D in the prevention and the additional therapy of cancers].
    Speer G
    Magy Onkol; 2010 Dec; 54(4):303-14. PubMed ID: 21163761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D and prostate cancer.
    Stewart LV; Weigel NL
    Exp Biol Med (Maywood); 2004 Apr; 229(4):277-84. PubMed ID: 15044710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D, vitamin D receptor and the importance of its activation in patients with chronic kidney disease.
    Bover J; Egido J; Fernández-Giráldez E; Praga M; Solozábal-Campos C; Torregrosa JV; Martínez-Castelao A
    Nefrologia; 2015; 35(1):28-41. PubMed ID: 25611831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D: considerations in the continued development as an agent for cancer prevention and therapy.
    Trump DL; Deeb KK; Johnson CS
    Cancer J; 2010; 16(1):1-9. PubMed ID: 20164683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent 19-norvitamin D analogs for prostate and liver cancer therapy.
    Kittaka A; Yoshida A; Chiang KC; Takano M; Sawada D; Sakaki T; Chen TC
    Future Med Chem; 2012 Oct; 4(16):2049-65. PubMed ID: 23157238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.